000			02240na a2200277 4500
999			_c14185 _d14185
003			PC14185
005			20200110114224.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aLópez Medrano, Francisco _9162 _eEnfermedades Infecciosas
245	0	0	_aHow to assist clinicians in improving antimicrobial prescribing: Tools and interventions provided by stewardship programs. _h[artículo]
260			_bEnfermedades infecciosas y microbiología clínica, _c2013
300			_a31 Suppl 4:38-44.
500			_aFormato Vancouver: López-Medrano F, Moreno-Ramos F, de Cueto M, Mora-Rillo M, Salavert M. How to assist clinicians in improving antimicrobial prescribing: tools and interventions provided by stewardship programs. Enferm Infecc Microbiol Clin. 2013 Sep;31 Suppl 4:38-44.
501			_aPMID: 24129288
504			_aContiene 62 referencias
520			_aIn the last decade, there has been an exponential increase in the microorganisms resistant to antimicrobials and a significant increase in the cost of these types of drugs. This phenomenon has increased interest in the development of interventions for counseling on and control of the use of antimicrobials, referred to as stewardship programs. In this article we review, from various points of view, the tools that have been developed with this purpose. First, we highlight the value of locally adapted guidelines and clinical pathways as an essential part of the operational process. Then we emphasize the importance of the relationship between microbiologists and clinicians for the accurate transmission of the information provided by blood cultures to make the most appropriate choice of antimicrobial for the patient's treatment. We also review the computerized tools that have facilitated the correct use of antimicrobials according to the controls established by the departments of pharmacy. Based on the previous tools, some programs based on "bedside recommendations" provided by multidisciplinary teams have been developed for optimizing the rational use of antimicrobials (PROA programs). Finally, we comment on the peculiarities of the programs targeting antifungals that have been developed in recent years.
710			_96 _aServicio de Medicina Interna
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc14185.pdf _ySolicitar documento
942			_n0 _2ddc _cART